Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers of the University of ...

Explore the reality of schizophrenia by debunking seven myths and offering compassionate insights into this complex mental ...

The vast majority of people in psychosis aren’t violent—but Cohen Miles-Rath was. Here's what that can teach us about mental ...

As per the Brain and Behavior Research Foundation, it combines two compounds called xanomeline and trospium chloride. This is ...

Stanford Medicine scientists are generating a periodic table of sorts for psychiatric disorders, providing a better ...

Researchers from Singapore's National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, ...

Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a ...

In this episode, NAMI CEO Dan Gillison, Jr. is joined by Chief Medical Officer Dr. Ken Duckworth to explore why the language ...

Could the largest market for the new schizophrenia drug xanomeline and trospium chloride (Cobenfy) be in Alzheimer's disease ...

Boehringer healthcare HCP Illustrative image Boehringer Ingelheim today announced top-line results from the Phase III CONNEX ...

But that system didn’t work well, as you may experience symptoms of different "types" of schizophrenia at different times. Now, experts describe schizophrenia as a spectrum disorder that ...

Schizophrenia is a serious and chronic brain disorder that affects a person’s ability to think clearly, manage emotions, make ...